Clinical trial reportAdvances in respiratory medicinePublished
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Regional connection
Verified An author affiliation on the Europe PMC record names Princeton University. Affiliation source
- Institution
- Princeton University
- County
- Mercer County
Publication record
- Type
- Clinical trial report
- Venue
- Advances in respiratory medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Antiviral Agents; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; COVID-19; COVID-19 Drug Treatment; RNA polymerase
- PubMed ID
- 38804439
- PubMed Central ID
- PMC11130936
- Open access
- Yes, open
- Added to directory
- Source checked